Miscellaneous
A costly, controversial new Alzheimer’s drug is sending shockwaves through the U.S. health care system. How are doctors grappling with questions about its safety and efficacy? This is the first episode in a special conversation series featuring different people reckoning with the potentially sweeping consequences this drug could have on millions of patients’ lives and billions of dollars in health care spending.Guest: Winston Chiong, MD, PhD, Associate Professor of Neurology, University of California, San FranciscoExplore the full series and additional resources: https://tradeoffs.org/aducanumabRead a transcript of this episode: https://tradeoffs.org/2021/06/22/aducanumab-doctor-transcript/Sign up for our weekly newsletter to see what research health policy experts are reading right now, plus recommendations from our staff: bit.ly/tradeoffsnewsletterSupport this type of journalism today, with a gift: https://tradeoffs.org/donateFollow us on Twitter: https://twitter.com/tradeoffspod See acast.com/privacy for privacy and opt-out information.